Geffa.
I don't really think it's necessary to go over this again.
FDA wanted an RCT. They didn't get one. Now, Si is going to do an RCT.
It's pretty straightforward.
If you are still going to deny the reality of the situation, you'll fall for it again next time.
- Forums
- ASX - By Stock
- MSB
- Ann: Update on BLA for Graft Versus Host Disease
Ann: Update on BLA for Graft Versus Host Disease, page-161
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B |
Open | High | Low | Value | Volume |
$1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23940 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 22571 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13940 | 1.390 |
1 | 14000 | 1.385 |
2 | 15350 | 1.370 |
2 | 20000 | 1.355 |
2 | 2400 | 1.350 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 22571 | 2 |
1.400 | 108300 | 3 |
1.405 | 39000 | 3 |
1.410 | 1430 | 1 |
1.415 | 67966 | 3 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online